ABOUT COPYRIGHT

Conditions of MTC in sufferers treated with liraglutide, One more GLP-one receptor agonist, are already reported within the postmarketing period of time; the data in these reviews are inadequate to determine or exclude a causal connection concerning MTC and GLP-1 receptor agonist use in people.to reduce the chance of kidney condition worsening, kid